Implantable cardioverter defibrillators (ICDs) were found to have a beneficial effect on mortality in patients with chronic kidney disease (CKD). Mortality in patients with chronic kidney disease (CKD ...

Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . Patients with HF and CAD who increased their daily levels of physical activity after receiving an implantable ...

Please provide your email address to receive an email when new articles are posted on . Patients with scar-related ventricular tachycardia (VT) who received VT ablation plus a subcutaneous ICD had ...

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...

This article explores pacemaker and ICD system architecture, with a focus on connector types and interconnect technologies.

PROFID EHRA, the first clinical trial seeking to challenge routine implantation of defibrillators in heart attack survivors with heart failure has just been launched. The European Society of ...

PARIS, France—Early use of an implantable cardioverter-defibrillator (ICD) following PCI in patients at high risk of death is associated with a reduction in mortality over the long term, according to ...

Small increases in daily physical activity are associated with a boost in 1-year survival in patients with heart failure and coronary disease who received an implantable cardioverter defibrillator ...